NFKB1 and carcinoma: Using several large sets of human cancer samples, we detected frequent occurrence of PI in human cancers with several interesting features: PI is cancer cell-autonomous, readily detectable in human carcinoma cell lines; its repertoire is distinct from other common inflammatory signatures; and it doesn’t bear the phenotypic hallmarks nor some of the regulatory characteristics of common inflammatory reactions (e.g., NF-κB).